CLEVELAND, Ohio – Athersys Inc. said Thursday it has raised $10.4 million from investors and licensing partners during the third quarter to extend the company’s liquidity and stave off a potential bankruptcy filing. The regenerative medicine developer in Cleveland has been working since 1994 to develop MultiStem, an off-the-shelf therapy…Read More
Financially strapped Athersys raises 104M
